LifeStance Health (LFST) director receives 17,746 RSU equity grant

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

LifeStance Health Group director Teresa DeLuca received an equity grant. She acquired 17,746 shares of common stock in the form of restricted stock units (RSUs), which are rights to receive one share of common stock per unit at no cash cost. After this award, she directly holds 125,034 shares of the company’s common stock, indicating a larger equity stake aligned with shareholder interests through stock-based compensation rather than open-market purchases or sales.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider DeLuca Teresa

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	17,746	$0.00	--

Holdings After Transaction: Common Stock — 125,034 shares (Direct, null)

Footnotes (1)

[object Object]

Key Figures

RSUs granted: 17,746 units Post-transaction holdings: 125,034 shares Grant price: $0.0000 per share

3 metrics

RSUs granted 17,746 units Restricted stock unit grant of common stock equivalents

Post-transaction holdings 125,034 shares Total direct common stock holdings after grant

Grant price $0.0000 per share RSU grant recorded with no cash exercise price

Key Terms

restricted stock units, RSUs, Grant, award, or other acquisition, Form 4

4 terms

restricted stock units financial

"Includes 17,746 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

RSUs financial

"Includes 17,746 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock."

RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/07/2026 - 07:39 PM Accepted by SEC EDGAR 07/07/2026 - 07:38 PM

FAQ

What did LifeStance Health (LFST) director Teresa DeLuca report on this Form 4?

She reported receiving 17,746 restricted stock units of LifeStance common stock. These RSUs are stock-based compensation, not an open-market purchase, and increase her direct holdings to 125,034 shares following the transaction on July 2, 2026.

Is the LifeStance Health (LFST) Form 4 a stock purchase or a grant?

The filing reflects a grant of 17,746 restricted stock units, coded as a grant or award acquisition. The transaction price is listed as $0.0000 per share, confirming it is compensation, not an open-market purchase of LifeStance stock.

How many LifeStance Health (LFST) shares does Teresa DeLuca hold after this RSU grant?

After the grant, she directly holds 125,034 shares of LifeStance common stock. This figure includes the 17,746 restricted stock units, each representing a contingent right to receive one share of the company’s common stock in the future.

What are the restricted stock units (RSUs) reported in the LifeStance (LFST) Form 4?

The Form 4 notes 17,746 restricted stock units, each representing a contingent right to one share of common stock. These units are part of equity compensation and do not involve a cash purchase, with future settlement in shares subject to applicable conditions.

Does this LifeStance Health (LFST) insider filing show any stock sales?

The filing shows no stock sales by Teresa DeLuca. It reports only one acquisition transaction, a grant of 17,746 restricted stock units, with no indicated disposals or open-market sales of LifeStance common stock in this Form 4.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DeLuca Teresa

(Last)

(First)

(Middle)

C/O LIFESTANCE HEALTH GROUP, INC.

4800 N. SCOTTSDALE ROAD, SUITE 2500

(Street)

SCOTTSDALE

ARIZONA

85251

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
LifeStance Health Group, Inc. [ LFST ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	07/02/2026		A		17,746⁽¹⁾	A	$0.00	125,034	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Includes 17,746 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

	By: /s/ Ryan Pardo, Attorney-in-Fact	07/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR